Studies related to Interleukin 6 and Zinc

Zinc Decreases C-reactive Protein, Lipid Peroxidation, And Inflammatory Cytokines In Elderly Subjects: A Potential Implication Of Zinc As An Atheroprotective Agent

Effect Decrease
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 40
Sex Both Genders
Age Range 45-64, 65+
Body Types Average
Notes for this study:
45mg elemental zinc (as gluconate) daily to otherwise healthy elderly subjects for six months is associated with improvements in the inflammatory status of the body, suggesting a reduction in artherosclerotic potential.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.